Simple Summary Magnetic resonance (MR) imaging had limited clinical indications in
patients with thoracic malignancies in the last a few decades. However, technical advances …

Background There have been conflicting results regarding fluorine 18–labeled
fluorodeoxyglucose (18F-FDG) PET/MRI diagnostic performance in lung malignant …

Diffusion-weighted imaging (DWI) is a fundamental sequence not only in neuroimaging but
also in oncologic imaging and has emerging applications for MRI evaluation of the chest …

Background As a first-line imaging modality, whole-body fluorine-18 fluorodeoxyglucose
(18F-FDG) positron emission tomography (PET)/computed tomography (CT) and 18F-FDG …

Background Positron emission tomography (PET)/MRI combines the characteristics of
metabolism imaging and high soft tissue resolution, and could provide high diagnostic …

Objectives To calculate the pooled diagnostic performances of whole-body [18F] FDG
PET/MR in M staging of [18F] FDG-avid cancer entities. Methods A diagnostic meta-analysis …

Lung cancer is the leading cause of cancer-related mortality globally. Imaging is essential in
the screening, diagnosis, staging, response assessment, and surveillance of patients with …

Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT), has become a critical advanced imaging technique in oncology. With PET …

In clinical routine of patients suffering from lung cancer, radiotherapy/radiation oncology
represents one of the therapeutic hallmarks in the multimodal treatment besides or in …

Since lung magnetic resonance imaging (MRI) became clinically available, limited clinical
utility has been suggested for applying MRI to lung diseases. Moreover, clinical applications …